BOOT +6.6%, NTUS +6.1%, EXEL +5.2%, PKI +5.2%, FOLD +4.1%, TLYS +3.9%, EXAS +3.6%, AVTR +3.3%, EBS +3%, NSTG +2.3%, GILD +2%, CDNA +1.5%, AZZ +1.2%, NVCR +1% Other news:
MESO +70.3% (single dose of Rexlemestrocel-L provides substantial and durable reduction in heart attacks, strokes and cardiac death in patients with chronic heart failure) BNGO +24.3% (announces the kick-off of its next-generation cytogenomics symposium, the largest event yet to showcase saphyr's utility in genome analysis for genetic disease and cancer) SECO +23.2% (announces receipt of preliminary non-binding "going private" proposal) LLY +14.5% (Donanemab slows clinical decline of Alzheimer's disease in "positive" Phase 2 trial) ORIC +11.2% (provides corporate update and highlights key 2021 milestones; Three IND/CTA filings for ORIC-533, -944, and -114 expected in 2021) NIO +11% (NIO partners with NVIDIA (NVDA) to develop a new generation of automated driving electric vehicles) XCUR +10.5% (granted two fast track designations for Cavrotolimod (AST-008) from the FDA) WBAI +7.5% (expects to issue ~$14.4 mln worth of its Class A ordinary shares as consideration to acquire bitcoin mining machines owned by the Sellers) PASG +7.3% (announces plan to deliver on multiple meaningful catalysts in 2021) ATRA +6.8% Presenting at JP Morgan Healthcare Conf) PACB +5.2% (SoftBank has taken a 6% stake in PACB, according to Bloomberg) BLUE +5.1% (Bluebirdbio to separate oncology business into independent company) CYTK +4.3% (FDA granted orphan drug designation to CK-3773274 (CK-274) for the treatment of symptomatic hypertrophic cardiomyopathy) BIDU +3.4% (confirms plans to establish an intelligent EV company and form strategic partnership with Geely (GELYY)) KXIN +3.2% (a
No comments:
Post a Comment